Net Cash Provided by (Used in) Operating Activities |
182M |
USD |
+25.5% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-2.36B |
USD |
+41.4% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
2.33B |
USD |
+26.1% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
1.13B |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
465M |
shares |
+0.22% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
155M |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.79B |
USD |
-0.29% |
Q3 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
866M |
USD |
+2.49% |
Q1 2024 |
Q1 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
39M |
USD |
-87.8% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
11M |
USD |
-8.33% |
Q4 2023 |
FY 2023 |
Unrecognized Tax Benefits |
48.5M |
USD |
-4.34% |
Q4 2023 |
FY 2023 |
Amortization of Intangible Assets |
2M |
USD |
-33.3% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
342M |
USD |
-16% |
Q4 2023 |
FY 2023 |
Interest Expense |
3.52B |
USD |
+10% |
Q2 2024 |
Q2 2024 |